Support and Resistance Levels
Past performance
About Solara Active Pharma Sciences Ltd Solara Active Pharma Sciences Limited, established in 2017, specializes in the manufacture, production, and distribution of active pharmaceutical ingredients (APIs). The company operates six manufacturing plants across India and maintains two R&D centers equipped with advanced facilities in Chennai and Bengaluru. Solara offers a diverse range of over 80 commercial APIs, focusing on niche, high-value pharmaceutical segments such as anthelmintics, anti-malarias, anti-infectives, and neuromuscular insomnia treatments.
Solara's manufacturing facilities are internationally recognized, holding approvals from key regulatory bodies such as the USFDA, EDQM, and WHO, among others. The company has expanded through strategic acquisitions, including Strides Chemicals and Sequent Penems, although it later divested its stake in Sequent Penems in 2024. With a robust pipeline of over 25 products under development, Solara continues to enhance its market position by launching products tailored to specific markets, thereby reinforcing competitive entry barriers and building intrinsic value.